| Amount | Holding |
|---|---|
| 1.98% | Everbridge Inc |
| 1.98% | MyoKardia Inc |
| 1.96% | argenx SE ADR |
| 1.86% | Mercury Systems Inc |
| 1.79% | Inphi Corp |
| 1.75% | Global Blood Therapeutics Inc |
| 1.68% | Tandem Diabetes Care Inc |
| 1.63% | Endava PLC ADR |
| 1.62% | FTI Consulting Inc |
| 1.62% | Teladoc Health Inc |
| 1.57% | RingCentral Inc Class A |
| 1.54% | Ascendis Pharma A/S ADR |
| 1.51% | Axon Enterprise Inc |
| 1.47% | Natera Inc |
| 1.44% | Repligen Corp |
| 1.42% | Five9 Inc |
| 1.34% | Inspire Medical Systems Inc |
| 1.29% | SpringWorks Therapeutics Inc Ordinary Shares |
| 1.23% | Cytokinetics Inc |
| 1.13% | Applied Therapeutics Inc |
| 1.11% | NeoGenomics Inc |
| 1.08% | Halozyme Therapeutics Inc |
| 1.07% | Fastly Inc |
| 1.06% | KBR Inc |
| 1.05% | Papa John's International Inc |
Expense Ratio Rating
6 /10
Expense Rating
0 /10
Market Score
3 /10
Category Score
5 /10
Market Size
3 /10
$DVSMX Alternatives
33%
FI Score
- dvsmx
- Mutual Fund
- US Stocks
- Small Growth
Driehaus Small Cap Growth Fund Investor Class
Expenses: 1.17% (Better than 1% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why ยป